Anthropy23 returned to The Eden Project in Cornwall for its second year in November, once more bringing together cross-industry companies and individuals united in a shared goal: to seek su
Donovan Quill, AscellaHealth’s Executive Vice President of Growth and Strategy, describes the unique challenges associated with bringing new specialty and rare disease pharmaceutical produc
Cell and gene therapies (CGT) offer immense potential for healthcare – opening up countless possibilities for saving and improving lives, which were previously unavailable through existing
Veeva Systems held its R&D and Quality Summit in Madrid from 5th to 7th June, once more returned to the Marriot Auditorium & Conference Centre – which only just about held the event
